Supportive and symptomatic management of amyotrophic lateral sclerosis

@article{Hobson2016SupportiveAS,
  title={Supportive and symptomatic management of amyotrophic lateral sclerosis},
  author={Esther V Hobson and Christopher J Mcdermott},
  journal={Nature Reviews Neurology},
  year={2016},
  volume={12},
  pages={526-538}
}
The main aims in the care of individuals with amyotrophic lateral sclerosis (ALS) are to minimize morbidity and maximize quality of life. Although no cure exists for ALS, supportive and symptomatic care provided by a specialist multidisciplinary team can improve survival. The basis for supportive management is shifting from expert consensus guidelines towards an evidence-based approach, which encourages the use of effective treatments and could reduce the risk of harm caused by ineffective or… 
Symptom management in amyotrophic lateral sclerosis: We can do better
TLDR
The study presented by Nicholson and colleagues in this issue provides insight into the current state of symptom management of a cohort of ALS patients and calls attention to the relatively high prevalence of anxiety and depression, consistent with the overall significant psychological morbidity noted in patients with ALS.
Multidisciplinary care in Amyotrophic Lateral Sclerosis: a systematic review and meta-analysis
TLDR
Multidisciplinary care is more effective than general neurology care at improving survival of patients with ALS, but only improves mental health outcomes related to quality of life of these patients.
Quality of life and functional independence in amyotrophic lateral sclerosis: A systematic review
TLDR
A systematic review of treatment protocols and their outcomes from clinical trials with focus on ALS rehabilitation that evaluated the effects on quality of life and functional independence from their intervention process found 11 studies met the inclusion criteria.
Polish Association for Palliative Medicine stand on qualification for palliative care and management of patients with amyotrophic lateral sclerosis and multiple sclerosis
TLDR
The burden of care in the advanced stage of the disease should be transferred from functional improvement of the patient to limitation of suffering and providing the patient with comfort.
Gastrostomy and mechanical ventilation in amyotrophic lateral sclerosis: how best to support the decision-making process?
TLDR
An overview of the life-sustaining methods used in ALS and their effects on disease progression, survival and quality of life of patients and their caregivers is presented.
A perspective on therapies for amyotrophic lateral sclerosis: can disease progression be curbed?
  • Xiaojiao Xu, Dingding Shen, +7 authors Sheng Chen
  • Medicine
    Translational neurodegeneration
  • 2021
TLDR
Current and prospective therapies for ALS are summarized and stem cell therapies, gene therapies, and newly-developed biomaterials have great potentials in alleviating neurodegeneration, which might halt the disease progression.
Reflections on the implementation of the provisional best practices guidelines for the evaluation of bulbar dysfunction in ALS
TLDR
The Provisional Best Practices Guidelines for the Evaluation of Bulbar Dysfunction in ALS by Pattee et al, published in this edition of Muscle & Nerve, represents a landmark accomplishment in the field and the authors are congratulated on this work.
The Palliative Care information needs of patients with amyotrophic lateral sclerosis and their informal caregivers: a scoping review.
CONTEXT Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disease, associated with impaired quality of life for patients and caregivers. As treatment is largely supportive, early
Diagnostics of Amyotrophic Lateral Sclerosis: Up to Date
TLDR
The typical form of ALS with upper and lower motoneuron involvement and progressive bulbar paralysis with bulbar muscle involvement is observed and survival may be prolonged based on prompt diagnosis, ALS subtype and proper management with supportive treatment.
Amyotrophic Lateral Sclerosis: An Acupuncture Approach
TLDR
Useful points for the treatment of bulbar paralysis, paralysis of upper and lower extremities, and correction of underlying Disharmony Patterns are discussed and an illustrative case is presented to demonstrate the acupuncture approach for treating ALS.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 123 REFERENCES
Is tracheostomy still an option in amyotrophic lateral sclerosis? Reflections of a multidisciplinary work group.
TLDR
Current practice in Switzerland and France tends to discourage the use of TPPV in ALS, and improved management of secretions and use of different interfaces allows NIV to be used 24-hours-a-day for prolonged periods, thus avoidingTPPV in many cases.
Practice Parameter update: The care of the patient with amyotrophic lateral sclerosis: Multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review)
Objective: To systematically review evidence bearing on the management of patients with amyotrophic lateral sclerosis (ALS). Methods: The authors analyzed studies from 1998 to 2007 to update the 1999
End-of-life management in patients with amyotrophic lateral sclerosis
TLDR
Clinical management of the end of life should aim to maximise quality of life of both the patient and caregiver and, when possible, incorporate appropriate palliation of distressing physical, psychosocial, and existential distress.
Is There a Role for Exercise in the Management of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis?
  • E. Plowman
  • Psychology, Medicine
    Journal of speech, language, and hearing research : JSLHR
  • 2015
TLDR
Insufficient data exist to support or refute the role of exercise in the management of bulbar dysfunction in PALS, and this represents a critical area of future investigation.
Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial
TLDR
In patients with amyotrophic lateral sclerosis without severe bulbar dysfunction, NIV improves survival with maintenance of, and improvement in, quality of life and the survival benefit from NIV in this group is much greater than that from currently available neuroprotective therapy.
Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
TLDR
Riluzole 100 mg per day appears to be modestly effective in prolonging survival for patients with ALS.
Depression and Anxiety in Individuals with Amyotrophic Lateral Sclerosis
TLDR
Evidence from other patient groups, such as elderly patients diagnosed with major depressive disorder, suggests that a combination of both therapies has the potential to also improve depression and anxiety in patients with ALS.
Identifying who will benefit from non-invasive ventilation in amyotrophic lateral sclerosis/motor neurone disease in a clinical cohort
TLDR
Data confirm that NIV improves survival in MND/ALS and the overall magnitude of benefit is 13 months and was largest in those with ALS-bulbar disease.
A multidisciplinary clinic approach improves survival in ALS: a comparative study of ALS in Ireland and Northern Ireland
TLDR
It is proposed that multiple decision-making processes within a multidisciplinary setting lead to an enriched set of clinical encounters for the patient and carer that enhances clinical outcome.
Early treatment with noninvasive positive pressure ventilation prolongs survival in Amyotrophic Lateral Sclerosis patients with nocturnal respiratory insufficiency
TLDR
Investigating 1 year survival of ALS patients with FVC < 75% and nocturnal respiratory insufficiency, treated with NPPV, compared to a well-matched population ofALS patients, demonstrates that early treatment with N PPV prolongs survival and reduces decline of FVC% in ALS.
...
1
2
3
4
5
...